Literature DB >> 4103098

Lymphocyte and platelet autoantibodies in S.L.E.

P Stastny, M Ziff.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 4103098     DOI： 10.1016/s0140-6736(71)91751-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  New lymphokines produced by SLE sera stimulated lymphocytes: the PNAF (polymorphonuclear activating factors).

Authors:  M T Labro-Bryskier; C Babin-Chevaye; J Hakim
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

2.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

3.  Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.

Authors:  W Glinski; M E Gershwin; A D Steinberg
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

4.  Antibody-associated lymphotoxin in acute infection.

Authors:  S W Huang; D B Lattos; D B Nelson; K Reeb; R Hong
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

5.  Systemic lupus erythematosus, repeated abortions, and thrombocytopenia.

Authors:  M H Pritchard; J D Jessop; P M Trenchard; J A Whittaker
Journal:  Ann Rheum Dis       Date:  1978-10       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.